Takeda Pharmaceutical Company Limited's Asia Pacific Primary Care Portfolio
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Takeda Pharmaceutical Company Limited's Asia Pacific Primary Care Portfolio - overview
Location
-, Osaka, Japan
Primary Industry
Pharmaceuticals
About
Based in Chuo-ku, Japan, Takeda Pharmaceutical Company Limited's Asia Pacific Primary Care Portfolio covers the company's 18 primary care products, which includes over-the-counter and prescription drugs, sold in Australia, Hong Kong, Macau, Malaysia, Philippines, Singapore, South Korea, Taiwan and Thailand. In January 2024, CBC Group and Dong-A Socio Holdings acquired Takeda Pharmaceutical Company Limited's Asia Pacific Primary Care Portfolio from Celltrion, Inc. for KRW 247. 1 billion.
Current Investors
Celltrion, Inc., CBC Group, Dong-A Socio Holdings
Primary Industry
Pharmaceuticals
Sub Industries
Pharmaceuticals
Company Stage
Add-on
Total Amount Raised
Subscriber access only
Takeda Pharmaceutical Company Limited's Asia Pacific Primary Care Portfolio - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Spin-Off | Completed | Takeda Pharmaceutical Company Limited's Asia Pacific Primary Care Portfolio | - | ||||||||
| Add-on | Completed | Takeda Pharmaceutical Company Limited's Asia Pacific Primary Care Portfolio | - |
Displaying 1 - 2 of 2
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.